1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow Adjuvance Technologies, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pertussis Acellular Vaccine Adjuvanted With TQL1055 TQL1055, Acellular pertussis vaccine - Pertussis | Phase 1 | Terminated | Adjuvance Technologies, Inc. | 72 | 2021-04-06 | 2022-11-01 |
Whooping Cough (1)
Australia (1)